Fund moves

Danaher Corporation (DHR): Welch & Forbes LLC added to its stake +8,703 shares

Welch & Forbes LLC added to its stake in Danaher Corporation, per its Q4 2024 13F.

685K
Shares reported · +8,703 vs prior quarter
2.0%
Disclosed portfolio weight
$157M
Reported value
Holdings as of
Dec 31, 2024
Filed
Feb 7, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 15, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  2. Jan 30, 2025InsiderOfficer sold ~$1.28M of DHR shares in the open market
  3. Feb 7, 2025InsiderDirector sold ~$114K of DHR shares in the open market

What came next

  1. Feb 13, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  2. Feb 25, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  3. Feb 26, 2025CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
  4. Mar 4, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
  5. Mar 5, 2025FDAFDA device clearance: Access Cortisol; DxC 500i Clinical Analyzer
  6. Mar 17, 2025FDARecall: DxC 500 AU Clinical Chemistry Analyzer, Catalog Numbers/UDI codes: C63519 / 14987666545058 C63520 / 14987666545065 Software versions: V1.3, V1.4, V1.4.1, V1.4.…
  7. Mar 20, 2025FDARecall: DxC 500 AU Clinical Chemistry Analyzer, Catalog Numbers/UDI codes: C63519 / 14987666545058 C63520 / 14987666545065. The Beckman Coulter DxC 500 AU Clinical Che…
  8. Mar 21, 2025FDARecall: Radiometer ABL90 Series - Radiometer ABL90 FLEX Model Number 393-090 Radiometer ABL90 Series - Radiometer ABL90 FLEX PLUS Model Number 393-092 The Radiometer A…
  9. Mar 27, 2025FDARecall: Beckman Coulter DxI 9000 Access Immunoassay Analyzer
  10. Mar 27, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  11. Mar 28, 2025FDAFDA device clearance: Access Toxo IgG
  12. Apr 2, 2025FDARecall: HistoCore PELORIS 3, Model/Catalog Number: 45.0005/45.7512.501 A11, Software Version: 3.4.0. The HistoCore PELORIS 3 Rapid Tissue Processor is a dual retort ra…
  13. Apr 7, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  14. Apr 8, 2025FDARecall: REMISOL Advance UDI-DI code: 13700962601874 All Software Versions: B92487; B92488; C24317; C28652; C37500; D04164; C44703; C57017; C69412; C69413; C73942; C739…
  15. Apr 8, 2025CongressDisclosed purchase of DHR — reported range $15,001 - $50,000
  16. Apr 11, 2025CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
  17. Apr 21, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  18. Apr 23, 2025FDARecall: Apo B Reagent, REF: OSR6143
  19. Apr 23, 2025FDARecall: DxI 9000 Access Immunoassay Analyzer, Catalog Number C11137, running software version 1.20
  20. Apr 23, 2025FDARecall: DxI 9000 Access Immunoassay Analyzer, Catalog Number C11137, running software versions 1.20
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

How this filing works

Explore the data

Common questions

What does this filing report about Danaher Corporation (DHR) stock?

Welch & Forbes LLC added to its stake in Danaher Corporation, per its Q4 2024 13F. Now 685K shares, $157M reported value, 2.0% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Dec 31, 2024. Filed: Feb 7, 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Danaher Corporation recently?

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days. They are listed on the DHR page.

Does this mean DHR stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Danaher Corporation

Everything OQRO holds on this company is on its DHR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data